UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
July 01, 2020 16:05 ET
|
Unity Biotechnology, Inc.
– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 – SOUTH...
UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
June 11, 2020 14:31 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, June 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
May 28, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
May 07, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting...
UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
May 04, 2020 16:30 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
March 31, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
March 30, 2020 17:20 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. today announced that Anirvan Ghosh, Ph.D., has officially joined the company as Chief Executive Officer. As...
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
March 11, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
March 03, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer
March 02, 2020 16:30 ET
|
Unity Biotechnology, Inc.
– Renowned Scientist and Drug Developer Joins UNITY’s Mission to Extend Healthspan – – Succeeds Keith Leonard Who Will Continue as Chairman – SAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) --...